Navigation Links
Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
Date:3/16/2008

SALT LAKE CITY Two major eye diseases and leading causes of blindnessage-related macular degeneration and diabetic retinopathycan be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other institutions have announced in a new study.

Damage from both diseases was prevented and even reversed when the protein, Robo4, was activated in mice models that simulate age-related macular degeneration (AMD) and diabetic retinopathy, according to Dean Y. Li, M.D., Ph.D., senior author of the study published March 16 in Nature Medicine online.

Robo4 treated and prevented the diseases by inhibiting abnormal blood vessel growth and by stabilizing blood vessels to prevent leakage. Abnormal blood vessel growth and leakage are two primary factors in both age-related macular degeneration (AMD) and diabetic retinopathy. But the studys ramifications go beyond eye diseases.

Serious infections such as SARS (Severe Acute Respiratory Syndrome), for example, kill people when an infection destabilizes blood vessels, allowing fluids to leak into the lungs. Tumors hijack blood vessel growth to feed on nutrients and grow. Although this study did not prove Robo4 would treat those diseases, Li believes it merits investigation.

Many diseases are caused by injury or inflammation destabilizing blood vessels and causing them to leak fluid into adjacent tissues as well, said Li, professor of internal medicine and an investigator with the Universitys Program in Human Molecular Biology and Genetics. We found a natural pathway the Robo4 pathway that counterattacks this by stabilizing blood vessels.

This discovery has significant implications for developing drugs that activate Robo4 to treat AMD and diabetic retinopathy, said Kang Zhang, M.D., Ph.D., associate professor of ophthalmology and visual sciences at the University of Utahs John A. Moran Eye
'/>"/>

Contact: Chris Nelson
christopher.nelson@hsc.utah.edu
801-581-7387
University of Utah Health Sciences
Source:Eurekalert

4

GOOD

Page: 1 2 3

Related biology news :

1. Diabetes makes it hard for blood vessels to relax
2. Weill Cornell team discovers how brains own tPA helps regulate blood flow to neurons
3. High blood pressure in older adults traced to genes effects in blood vessels
4. Eltrombopag effective for hepatitis C patients with low blood-platelet counts
5. MIT works toward engineered blood vessels
6. Blood pressure drug telmisartan shows powerful activity against stroke
7. Protein controls blood vessel formation, offers new drug target
8. Looking through the eyes of a mouse, scientists monitor circulating cells in its bloodstream
9. Study of malaria parasite in patient blood finds distinct physiological states
10. Blood clotting protein linked to rheumatoid arthritis
11. Energy drinks may pose risks for people with high blood pressure, heart disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ore the thought telling it to flex can race down y...channelmust open in the surface of each cell in th...r the cell to action. New research* at the Nationa... allowed scientists to observe ion channels within...lly offering insights for future drug development....
(Date:12/2/2009)...y of Southampton,s School of Ocean and Earth Scien...thampton (NOCS) has formally described four new sp...l discovered the new species in the Smithsonian Co...y in Washington. Explaining the significance of th...largest crustaceans currently inhabiting Earth and...
(Date:12/1/2009)...ounce the publication of results from its Phase II...erability of its novel, intranasal drug/device pro...usitis with nasal polyps in Rhinology , the offic...ologic Societies. , Chronic rhinosinusitis with...icantly reduce a patient,s quality of life, causin...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2King crab family bigger than ever 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting 5506 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 5504 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 5504 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 5504 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 5504 4Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance 5502 1Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance 5502 2
...titis C Virus (HCV) infects up to 500,000 people i...gnosed. It is the single biggest cause of people r...collaborative effort with groups across Europe and...gham have found monoclonal antibodies which may be...s C treatment is expensive and not successful in a...
...nheim, September 04, 2007 - The term "biotechnolog...e to fear and hostility. Alan McHughen from the Un...reviews at large the current state public knowledg...lliteracy and the role of the media. How is coexis...s from agricultural biotech only big companies or...
...MBUS, Ohio More than a third of college athletes ...uggesting exercise-induced asthma, even in those a...ew study shows. , The findings, published in the... in Sports & Exercise, paralleled earlier findings...mong Olympic athletes. The work also underscores t...
Other Biology News:Possible hepatitis C vaccine 2How the public perceives biotech 2Study finds a high rate of asthma in college athletes 2
(Date:12/2/2009)...ewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ...harmaceutical company focused on endocrine therapy...and Drug Administration (FDA) has granted Fast Tra...inhibitor compound, perifosine (KRX-0401), for the.... Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX)...
(Date:12/2/2009)...PRNewswire/ -- According to the National Institute...diagnosed with diabetes already have some stage of...ge to the retina caused by leaky blood vessels, is...s and is one of the most feared diabetic complicat...ho,ve had diabetes for 10 years or more will exper...
(Date:12/1/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Chromium - Global Market Trends ,...m---Global-Market-Trends.html ,, Worldwide dem...ess steel, while growth in aerospace and industria... of chromium metal. Environmental constraints and ...
(Date:12/1/2009)... Harvest Technologies Corp. ( www.h...company sponsored 60-patient clinical trial conduc...India using the company,s BMAC System to treat pat...mia (CLI). Sri Ramachandra Medical Center is a Har...based in Chennai, India and one of the largest pri...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
...ILL OFFER DNA TESTING FOR $59.95, THE MOST AFFORDA... ANYWHERE -, SAN DIEGO, Sept. 8 Familybuilder t...e in San Diego, the launch of the,Familybuilder Gl...ilybuilder.com ) and the introduction of $59.95 D... anywhere., At Familybuilder.com, people can now ...
... A free paper helps visitor...such as finding multilingual help, electronica inf... of pre-show information useful in planning a trip... areas, conferences and events. It includes an ext...d show resources. , Munic...
...You should have so much patience to solder nanowir...ometer is a billionth of a meter.) , That,s why a...ins many silicon nanowires to many prepatterned el...Nanotech Briefs. , The process removes many diffi...parallel," says Sean Hearne, a Sandia National Lab...
Other Biology Technology:Familybuilder Launches the Familybuilder Global Network at DEMOfall 08 2Familybuilder Launches the Familybuilder Global Network at DEMOfall 08 3Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 2Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 3Parallel 'nano-soldering' technique chosen for year's top-50 by Nanotech Briefs 2
Pyrophosphate Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
beta-galactosidase Colorimetric Assay Kit from Cell Signaling Technology
Human Serum Type AB from Irvine Scientific
Normal Human Serum from CHEMICON
Biology Products: